DEPARTMENTS | DIRECTORY | ADVANCED SEARCH | SCHOOL HOME
School Home NYU School of Medicine

irb
 Today is Saturday, August 30th 2008
 
Guidance Documents
Decision Charts -
Human Subject Regulations Decision Charts
NYU SoM IRB Guidelines for Writing a Research Protocol
Guidance of Required Elements of a Protocol
Guidance on Determining Human Subjects Research
Guidance on Submitting a New Application
Guidance on Using an FDA Regulated Product
Guidance for the Investigator as a Sponsor
Guidance for Data Monitoring Plans
Guidance for Emergency Use of an IND
Guidance for Emergency Use of an IND-IDE
Guidelines for Research in Pregnant Women, Human Fetuses and Neonates
Guidance on Research with Prisoners
Guidelines for Involving Children in Research
Guidance for Cognitively Impaired
Guidance for Students and Employees in Research
Guidelines for Recruitment of Research Subjects
Guidelines for Advertisements for Research Subjects
Guidance on Genetic Research
Guidelines on Protocol Development for Genetic Research
Guidance on the Consent Process and Documentation
Guidelines of Requests for Waiver of Consent
Guidance on Assent of A Minor
Guidance for Non-English Speaking Subjects
Guidance on Verbal Consent
Guidance on Waiver of Parental Permission
Guidelines for Amending a Protocol
Guidance on Continuing Review and Final Closures
Essential Documents
Guidelines to Investigator Responsibilities
Letter for Sponsors - Reportable Events Policy
Guidance for Reportable Events and Reporting Unanticipated Problems
Reviews Preparatory to Research

Research Data Compilations

How many copies do I submit?
 

Amendments

Download this page in PDF | MS Word format.

amendments

When a study is approved by the IRB, the approval is generally for a one-year period. Investigators may request amendments to the study during that period, within limitations. Changes to the study protocol may not be implemented until approved by the IRB.

amendments represent changes in the protocol, the risk benefit assessment or the consent/authorization. The degree and significance of the changes affect whether the modification receives full or expedited review. In deciding whether changes are minor or major, the investigator considers the purpose of the study (the hypotheses), the population to be enrolled and the procedures to be performed. If the first of these three components will be revised significantly, or if any two of the components will be changed to some degree, then the changes may require submitting a revised IRB application for full review.

Amendment procedures

  • A letter to the IRB describing the change and the rationale.
  • Any approach materials or documents given to participants that are affected by the modification, such as consent and assent forms, approach letters, telephone scripts or questionnaires.

When the modification is approved, a copy of the approval is sent to the investigator.

Approval of an amendment does not alter the date of the study’s approval period. Renewal notices are sent based on the approval period previously assigned.

Please feel free to contact the IRB Office with questions.

 

IRB Resources
HRPP Accreditation Tutorial
IRB CITI Tutorials
Decision Charts -
Human Subject Regulations Decision Charts
IRB Newsletter
IRB Course Calendar
Policies and Procedures
HELP Downloading Forms
Lay Glossary
Useful Web Links
Sponsored Programs Administration (SPA)
Office of Clinical Trials (OCT)
Email a Suggestion or Comment to the IRB
Contact the IRB
GCRC Web Page
Instructions for Research Conducted at Bellevue
Printer-Friendly Version
Email this to a friend


Dept. Home | FAQs | IRB Forms | HIPAA Forms | Other Forms | Consent Templates | Info Sheets | Tool Kit | Schedule | Categories of Review | Policies | Glossary | Helpful Web Links | FWA | Contact